News

Post-Hormone Therapy Risk/Benefit Scenario Still Debated

Publish date: April 15, 2008
PDF Download

 

Associate editor Lorinda Bullock contributed to this article.

ELSEVIER GLOBAL MEDICAL NEWS

Pages

Recommended Reading

Cost Sharing Cuts Compliance on Mammograms : Mammography rates in plans that adopted cost sharing dropped 5% vs. a 3% rise in plans that did not.
MDedge ObGyn
Decline in Radiotherapy After BCS Seen as Recurrence Risk
MDedge ObGyn
Risk Behaviors Key to HIV Epidemic in U.S. Youth
MDedge ObGyn
Complication Rate 41% in ART Pregnancy Study
MDedge ObGyn
Restraint Warranted in Pap Tests for Teenagers
MDedge ObGyn
Cloudy Cervical Discharge Tied to M. genitalium
MDedge ObGyn
Letrozole Stems Breast Ca Return After Tamoxifen
MDedge ObGyn
Disease Activity, Ethnicity Mediate Risk of Ovarian Failure in SLE
MDedge ObGyn
FDA Finds Injectable Anemia Drug 'Not Approvable'
MDedge ObGyn
Use Additional Codes to Cope With Pay for Performance
MDedge ObGyn